Xcell Biosciences

About:

Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.

Twitter/X: XcellBio

Top Investors: LabCorp, Viking Global Investors, Casdin Capital, Nimble Ventures, Formic Ventures

Description:

Xcell Biosciences is a San Francisco-based life science start-up company that is developing novel and disruptive systems for cell therapy development and production. Their proprietary technology enables fine control of primary cell phenotype and function, enabling an entirely new capability for optimizing efficacy and persistence of immune cell therapies.

Total Funding Amount:

$39.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2012-01-01

Contact Email:

innovate(AT)xcellbio.com

Founders:

Brian Feth, Ilya Kupershmidt, James Lim

Number of Employees:

11-50

Last Funding Date:

2024-04-01

IPO Status:

Private

Industries: